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Introduction. Since 2016, as part of the PSSO_01 multi-centre research project conducted under the auspices of the 
Polish Society of Surgical Oncology, clinical data on rectal cancer treatment have been collected. The objective of the 
study was to illustrate the state of early results of surgical treatment. 
Material and methods. The research project is multi-centre in nature. Data shall be collected electronically. The 
study protocol does not impose or suggest any course of procedure. It only systematizes the way data are collected 
for scientific purposes. The analysis of early results of surgical treatment was compared with the results of population 
studies from other European countries (Netherlands, Belgium).
Results. By the end of June 2018, 736 patients were registered in the study. In 399 (54.2%) an anterior resection was 
performed. More than half of patients undergoing subsequent surgical treatment (54.2%) receive neoadjuvant tre-
atment, with the percentage of patients undergoing radiotherapy or radiochemical treatment for lower rectal cancer 
being about 70%. Most patients (96%) are operated in elective procedure. The percentage of laparoscopic surgeries is 
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Introduction
According to the National Cancer Registry (Krajowy Re-
jestr Nowotworów — KRN), 5816 cases of rectal cancer were 
reported in 2015 [1]. It is difficult to estimate the percentage of 
patients with newly diagnosed rectal cancer who underwent 
surgery, how many of these surgeries were of a radical nature, 
the percentage of combination treatment, in what percen-
tage of operated cases sphincter-saving procedures were 
possible and restoration of gastrointestinal continuity, and 
how many patients underwent laparoscopic surgery? These 
are just some of the questions about the surgical treatment 
of rectal cancer patients that we do not have answers to. We 
can only rely on data from individual centers, usually specia-
list ones. In 2016, under the auspices of the Polish Society of 
Surgical Oncology (PSSO), a multi-centre observational study 
PSSO_01 project was launched, the main objective of which 
is clinical verification of the proposed risk of anastomotic 
leak after anterior resection. The study collects data on all 
rectal cancer patients operated in the participating centers. 
We obtain information on the pretreatment stage of cancer, 
type of surgery, percentage of laparoscopic surgeries, com-
plications in the perioperative period, share of combination 
treatment (radiotherapy/radiochemiotherapy). In the case 
of anterior resection, we archive data on the occurrence of 
anastomotic leaks, the creation of a protective stoma and the 
restoration of the gastrointestinal tract continuity (closure of 
a protective stomata). The study is open and the size of the 
target group (patients undergoing anterior resection) was 
estimated at 846 cases. Although the study does not have 
the character of a register, the data collected so far make 
it possible to illustrate early results of surgical treatment of 
rectal cancer not only from the perspective of a single centre, 
but also on a national scale. 
Methodology and material
The research project was approved by the Bioethics 
Commission operating at the Maria Skłodowska-Curie In-
stitute — Oncology Center in Warsaw. The study is observa-
tional and non-interventional, which means that all patients 
are treated according to the applicable standards and at no 
stage of the study there is a need to perform any additio-
nal medical procedures other than those which, according 
to the doctor’s knowledge and experience, constitute the 
optimal way of management for the patient. Research data 
are collected electronically using an encrypted application 
owned by PSSO. All data collected centrally are anonymo-
us. Sensitive data such as PESEL number, gender, date of 
birth, initials of the patient’s given name and surname are 
not collected centrally, so identification of the patient is 
only possible at the research centre. The study protocol 
does not impose or suggest any course of procedure. It 
only systematizes the way data are collected for scientific 
purposes. The PSSO_01 project is open to centers that meet 
the following criteria: 
 — the number of patients with primary rectal cancer dia-
gnosis, surgically treated within 12 months ≥ 20
 — the number of anterior resections performed within 
1 year in patients with rectal cancer ≥ 10
 — possibility to monitor the appearance of postoperative 
complications within a minimum of 30 days after sur-
gery and distant results of surgical treatment within 
12 months after surgery.
Centers in which a protective stoma is routinely (in each 
case) performed as an integral part of a surgery defined as 
“low anterior resection” cannot be included in the study, 
except where resections with anastomosis at a distance 
≤ 3 cm from the anal verge are considered as low anterior 
resections. Recruitment of centers is open and including 
other centers is possible at any time during the project. 
Currently, 21 centers are registered, out of which 14 are 
active (Fig. 1). The target group are patients who meet the 
following criteria: 
 — primary rectal adenocarcinoma (lower limit of the tumor 
at a distance of up to 15 cm from the anal verge),
 — anterior resection of the rectum,
 — surgery according to total mesorectal excision (TME) 
standards or partial mesorectal excision in case of high 
tumor position. 
low (8.6%). Postoperative complications are observed in 21.1% of patients. Severe complications (grades III–V accor-
ding to Clavien-Dindo classification) occur in 7.6% of patients undergoing surgery. Postoperative mortality is 1.1%.
Discussion. Although the project does not have the character of a registry and does not allow for drawing wider 
conclusions concerning the compliance with the standards of qualification for neoadjuvant treatment, the important 
information is that more than half of rectal cancer patients receive preoperative treatment, and the percentage of 
severe postoperative complications does not exceed 10%. 
Conclusions. The results of the PSSO_01 project are representative and reflect the actual situation concerning surgical 
treatment of rectal cancer patients in Poland. 
NOWOTWORY J Oncol 2018; 68, 3: 119–126
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The study protocol requires that all patients with pri-
mary rectal adenocarcinoma diagnosed, who come to the 
centre for surgical treatment — regardless of the type of 
operation — must be reported. This is necessary to demon-
strate that the material of patients qualified for detailed 
analysis of the target group was not subject to selection 
(the condition of publication in the indexed medical li-
terature according to STROBE Statement criteria). Data 
collected in the study centre are reported electronically, 
after the registration of the centre and gaining access to 
the research application. It was assumed that the time ne-
eded to gather an appropriate group of patients to achieve 
the objectives of the study would be from 36 to 48 months 
(depending on the number of centers participating in the 
study). The protocol allows for the possibility of including 
additional centers during the implementation of the rese-
arch project. The course of the study is supervised by the 
Coordinating Committee appointed by the Board of PSSO. 
By the end of June 2018, 736 patients were registered 
in the study (471 men and 265 women). In 399 (54.2%) 
anterior resection was performed (Fig. 2). In 433 (58.8%) 
cases comorbidities were reported, which may increase 
the risk of complications in surgical treatment (diabetes, 
hypertension, ischemic heart disease) and/or positive hi-
story of abdominal surgery. Moreover, as early as at the 
time of diagnosis of cancer, distant metastases occurred 
in 87 (11.8%) patients qualified for surgical treatment. The 
current rate of recruitment allows us to assume that the size 
of the target group will be reached within the expected 
period of time. 
Results of the analysis
Preoperative treatment
Neoadjuvant treatment is received by more than half of 
patients undergoing subsequent surgical treatment (54.2%). 
In the analyzed sample of 736 patients, high fractional dose 
radiotherapy (5 × 5 Gy) was used in 238 (32.3%) cases, while 
in 43 (5.8%) patients it was combined with chemotherapy. 
Classical “long” radiochemical treatment was received by 104 
(14.1%) patients. In 13 cases the only preoperative treatment 
was chemotherapy, in half of them the presence of distant me-
tastases was observed as early as at the moment of diagnosis. 
In 44 patients the only preoperative treatment was radiothe-
rapy with a total dose of 50.4 Gy in the form of monotherapy 
(without chemotherapy). It should be noted that the study 
protocol allows the inclusion of patients with upper rectal can-
cer in whom no preoperative treatment is used. Therefore, data 
relating to preoperative treatment require a detailed analysis, 
which is done in the chapter on surgical treatment. 
Surgical treatment
A vast majority of registered patients are operated in 
elective procedure. Collected data indicate that only 4% of 
patients required emergency surgery. The percentage of 
laparoscopic surgeries is also low: 8.6%. Radical oncological 
surgery (according to the surgeon) was performed in 624 
(84.8%) patients. The type of conducted surgeries has been 
shown in Figure 3. The most common types of rectal cancer 
resection surgeries are analyzed below. 
Anterior resection
In 198 (49.6%) patients radiotherapy or radiochemiothe-
rapy was applied before the surgery. In the case of anterior 
resection with low anastomosis, the preoperative treatment 
was received by 72.3% of patients. 
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Laparoscopic surgery was performed in 36 (9.0%) patients 
(reports from 8 out of 14 active centers). In 95% of cases the 
anastomosis was performed using the stapling technique. 
Most of the anastomoses were performed with the end-to-end 
method (94.5%). End-to-side anastomosis is performed much 
less frequently (4.3%), while anastomosis with the J-pouch 
bowel reservoir is performed sporadically (only 2 such cases 
from one research centre have been reported). The distances 
between the anal verge and the anastomosis are presented in 
Table I. If a low anterior resection is defined as a surgery with 
an anastomosis up to 5 cm from the anal verge, the percenta-
ge of such procedures reaches 19.2%. In 90 (22.6%) patients, 
anastomosis requires initiating the left colon bend, which is 
a value similar to the reported percentage of resections with 
low anastomosis. In 91 (22.8%) cases the surgeon secured the 
anastomosis with a stoma. Out of 87 patients operated until 
the end of December 2017, in whom the surgeon secured the 
anastomosis with a stoma more than 6 months after surgery, 
30 (34.4%) still have a stoma, including 8 (9.2%) patients with 
a stoma longer than 12 months after surgery and it may be 
assumed that the stoma is already permanent. 
Abdominosacral resection
The study protocol does not distinguish between ab-
dominosacral and abdominoperineal resections, assuming 
that these are cylindrical amputations with an appropriate 
margin within the pelvic floor and the tissues located above. 
All such surgeries should be classified as elective (100% 
of reported cases). The majority of patients undergoing 
abdominosacral amputation receive preoperative treat-
ment — 77.2%. The operation is usually performed with the 
intention of oncological radicality — 96.6%. The percentage 
of laparoscopic surgeries is low — 12.8%. 
Hartmann’s procedure
In the majority of patients operated in this way, pre-
operative radiotherapy or radiochemical therapy is used 
(62.1%). This type of resection is more frequent in patients 
with a history of abdominal surgery and/or comorbidities 
— 66.7% and with the presence of synchronous distant 
metastases — 20.7% (Table II). In 16.1% of cases resection is 
palliative. Hartmann’s laparoscopic procedure is performed 
rarely (2 cases reported). 
Operations related to the creation of an intestinal stoma
The total percentage of patients with an intestinal stoma 
as a result of the surgery is 46.9%. Of these, in 12.2% of cases 
it is by definition a temporary stoma. However, observations 
made within 6 months after surgery indicate that 47.2% of 
patients still have an intestinal stoma and one should su-
spect that it may be a permanent stoma. Considering only 
radical surgeries, the percentage of patients with a perma-
nent intestinal stoma is 42%. 
Postoperative complications
Postoperative complications were observed in 21.1% of 
patients. The grade and severity of reported complications 
were determined according to the Clavien-Dindo classi-
fication [2] — Table III. Postoperative mortality was 1.1%. 
Severe complications requiring surgical treatment or ICU-
-management (grades III and IV) occurred in 7.6% of patients 
undergoing surgery. The total percentage of complications 
depending on the type of operation is presented in Figure 
4. The highest risk of complications is associated with an-
terior resection with low anastomosis (up to 5 cm from the 
anal verge) (29.1%). The risk of anastomosis leaks is 10.6% 
in such case. A creation of a protective stoma reduces the 
risk of symptomatic leak, but it is still a high percentage 
of 9.9%. This is one of the reasons why a protective (tem-
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Figure 3. Type of performed surgeries 
Table I. Distance between the anastomosis and the anal verge
Distance range Number of cases %
≤ 3 cm 35 8.8
> 3–5 cm 106 26.8
> 5–10 cm 191 48.2
> 10 cm 64 16.2
No data available 3 –
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porary) stoma remains open and becomes a permanent 
stoma. A risk of severe (grades: III–V) complications after 
abdominosacral amputation is 7.4% and is lower than after 
Hartmann’s procedure: 10.3%. Overall, radical surgeries carry 
a higher risk of postoperative complications than palliative 
surgeries (22.1% vs 16.1%), but the percentage of severe 
complications (grades: III–V) is similar to that observed after 
palliative surgery: 8.7% vs 9.4% It should be noted that in 
the group of palliative surgeries non-resectional procedu-
res predominate. The percentages of severe postoperative 
complications after certain types of rectal cancer resections 
are presented in Table IV. 
PSSO_01 against the background of European 
research
The PSSO_01 research project does not meet the requ-
irements of the register of rectal cancer surgical treatment, 
however, to the best knowledge of the authors of this report 
it is the first study based on prospectively collected clinical 
material, which allows for presenting collective results of 
surgical treatment from both large and smaller centers in 
Poland. The data collected so far have been compared with 
the results of the Dutch Surgical Colorectal Audit [DSCA] [3] 
and the Belgian project PROCARE [4] — Table V. The Dutch 
Surgical Colorectal Audit was carried out in 2009–2011. In 
the following years, the audit covered 80%, 92% and 95% 
of patients treated surgically for colorectal cancer in the 
Netherlands. Rectal cancer is defined as tumors located up 
to 12 cm from the anal verge. The lesions located above were 
analyzed as colon cancer. An unquestionable success of the 
Dutch audit was the unification of standards of diagnostic 
and therapeutic management in Dutch hospitals, which 
resulted in the lack of differences between the results of 
oncological treatment of patients operated in both large 
and smaller centers [5]. Launched in 2006, the multi-centre 
PROCARE project focused on the results of treatment of 
patients with lower and middle rectal cancer (a cancerous 
tumor located 0–10 cm from the anal verge). The results 
obtained in PROCARE are of limited value, as only 37% of 
patients were included in the study.
Representativeness of the tested sample
Following the analysis made on the Dutch audit material, 
the PSSO_01 study identified large (over 50 rectal cancer/
year operations), medium (20–50 patients/year) and small 
(up to 20 patients/year) centers [5]. In the analysis of the 
Table II. Type of surgeries performed vs data from the patient history and the grade of cancer at the moment of diagnosis
Positive medical history* Synchronous metastases Urgent surgery 
Anterior resection 56.1% 7.5% 0.5%
Abdominosacral resection 63.1% 6.7% 0.0
Hartmann’s procedure 66.7% 20.7% 8.0%
Colostomy 49.2% 41.3% 22.2%
Local excision 87.5% 12.5% 12.5%
Laparotomy 60% 20.0% 0.0
Proctocolectomy 50% 0.0 0.0
* concerns comorbidities and/or surgical treatment within the abdominal cavity
Table III. Postoperative complications according to the Clavien-Dindo classification
Grade Definition Number of cases
n (%)
I Any deviation from the correct (uncomplicated) postoperative course, 
without the need for pharmacological, surgical, endoscopic treatment and without interventional 
radiology procedures
43 (5.8)
II Complications requiring pharmacological treatment. In addition, this group includes all cases 
requiring treatment:
– postoperative blood transfusion,
– total parenteral nutrition (except where total parenteral nutrition is a routine procedure arising from 
the type of surgery performed)
45 (6.1)
III Complications requiring surgical or endoscopic treatment or interventional radiology procedures 
– without general anaesthesia (IIIA)
– under general anaesthesia (IIIB)
40 (5.4)
IV All life-threatening postoperative complications requiring treatment in ICU conditions
– single organ failure (IVA)
– multiple organ failure (IVB)
16 (2.2)
V Death 8 (1.1)
No data available – 3 (–)
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PROCARE study, in order to determine the “volume” of the 
centre, the number of surgeries performed annually was also 
assumed, however, four groups were identified: < 30 surge-
ries/year; 30–50 / year; 50–100 / year and > 100 / year [4]. In 
the presented study for the purpose of comparative analysis, 
data from the last two groups of the PROCARE study have 
been combined. The results of PSSO_01 study are in this 
respect comparable to those presented by Dutch authors. 
They indicate that the vast majority of the reported patients 
are operated in medium-volume centers performing 20–50 
surgeries a year. Different numerical criteria adopted in the 
PROCARE study would indicate that the majority of patients 
are subject to surgeries in large centers (76.7%). However, 
if we assumed that the average Belgian centers operate 
between 30 and 100 patients a year, then the percentage 
of patients treated in this defined group would be 48%. 
In the PSSO_01 study material, it is worth noting that 
the number of men is twice as much as women. Comparing 
this with epidemiological data, which indicate a sustained 
trend in incidence in males and a plateau in incidence in 
females [1], the gender differences found in the analyzed 
group of patients seem to be representative for the gene-
ral population and comparable with the data from other 
reports [4, 5]. In the PSSO_01 project we are waiting for the 
age of registered patients analysis. Due to the fact that all 
sensitive data (age, PESEL) are stored in the centre, such an 
analysis will be possible only after the completion of the 
study and obtaining raw data from each centre separately. 
Although the recorded percentage of patients with 
synchronous distant metastases is comparable to those 
published in Dutch and Belgian reports, it seems to be unde-
restimated in comparison to the Polish population as far as 
the experience of a Polish clinician involved in rectal cancer 
surgery is concerned. Firstly, we do not have population 
data on the severity of the disease at the time of diagnosis 
among newly registered cases in Poland, and secondly, some 
of these patients are not qualified for surgical treatment at 
all, or are operated on a palliative basis in other centers as 
a matter of urgency. 
Nearly 60% of participants are patients with comorbi-
dities and/or history of abdominal surgery and this value is 
significantly lower than in the Dutch report (95%). However, 
the reason for these differences may be that the PSSO_01 
test protocol requires reporting only those cases where, in 
the opinion of the surgeon, comorbidities or surgical history 
are relevant to the planned surgery. 
Neoadjuvant treatment
Short-term (5-day) irradiation monotherapy up to a 
total dose of 25 Gy and long-term radiation therapy up to a 
total dose of 50.4 Gy in combination with chemotherapy are 
standard preoperative treatments for rectal cancer patients, 
depending on the cancer stage and the assessment of tumor 
resectivity. The results of a Polish multi-centre randomized 
clinical trial comparing the efficacy of classical radiochemical 
treatment with short term radiotherapy combined with che-
motherapy in the treatment of patients with primary non-
-resectional rectal cancer showed that the treatment results 
were similar [6]. The clinical application of these results is 
reflected in the increasing number of subgroups of patients 
treated preoperatively according to the following program-
me: short-term radiotherapy, chemotherapy and surgery. 
We found that 6% of patients (n = 44) received only long-
-term irradiation without chemotherapy. It is an acceptable 
method of treatment for patients with locally advanced 
Table IV. Type of resection surgery and risk of severe postoperative complications according to the Clavien-Dindo classification
Surgery type Grade III Grade IV Grade V
Low anterior resection 8.5% 3.5% –
Anterior resection 3.5% 1.6% 1.6%
Abdominosacral resection 5.4% 1.3% 0.7%
Hartmann’s procedure 5.0% 3.4% 2.3%
Local excision 12.5% – –
Figure 4. Postoperative complications depending on the surgery 
type
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cancer and with contraindications for systemic treatment. 
The total percentage of patients undergoing neoadjuvant 
treatment is similar to that reported in the PROCARE report 
(54.2% vs 59.5%) and significantly lower than in the study 
by Dutch authors (54.2% vs 83.7%) — Table V. The Dutch 
audit concerned patients with the diagnosis codified as C20 
according to ICD10 classification, but it should be noted that 
in 77.9% of registered patients cancer was located within 10 
cm from the anal verge [3]. This may explain the observed 
difference in the percentage of patients treated with neo-
adjuvant treatment between the PSSO_01 study report and 
the results of the Dutch audit. The analysis of a subgroup 
of patients with anterior resection with anastomosis up to 
10 cm from the anal verge or abdominosacral resection (i.e. 
those in whom the tumor location might indicate the need 
for preoperative treatment) shows that the percentage of 
patients receiving neoadjuvant treatment is 69.2%. 
Surgical treatment
Low percentage of laparoscopic surgeries in Poland is 
the most significant difference observed in comparative 
analysis — Table V. The Dutch audit completed in 2011 
indicated that the percentage of laparoscopic surgeries re-
ached 38.1%. A study conducted in 2015 in selected centers 
previously participating in the DSCA showed that the per-
centage of laparoscopic surgeries in small centers reaches 
59.8%, in medium centers — 44.8%, and in large centers — 
45.7%. The difference was statistically significant, indicating 
that the majority of laparoscopic surgeries are performed 
in small centers [5]. PSSO_01 project data indicate that in 
Poland the total percentage of such surgeries does not 
exceed 10%. The reasons for these differences cannot be 
found in the conducted surgeries mode, as the percentage 
of urgent procedures reported in the PSSO_01 project and 
DSCA results are similar: 4% vs 2.8%
The percentage of abdominosacral resections reported 
in PSSO_01 is almost identical to the PROCARE project re-
sults. On a global scale, this percentage may be significantly 
different, as both PSSO_01 and PROCARE covered only a 
part of the centers. 
An interesting observation is the comparison of the 
percentage of resections with the Hartmann’s procedure, 
Table V. PSSO_01 against the background of European studies
Feature Poland
PSSO_01
Belgium
PROCARE [4, 8]
Netherland
DSCA [3, 5]
Representativeness of the tested sample
Participation of centers in recruitment:
– small centers 
– medium-sized centers 
– large centers 
Gender:
– male
– female
Synchronous distant metastases
7.9%
60.7%
31.4%
64%
36%
11.8%
2.5% [4]
20.8% [4]
76.7% [4]
61% [4]
39% [4]
9.2% [4]
12.3% [5]
63.4% [5]
24.2% [5]
62% [3]
38% [3]
8.6% [5]
Neoadjuvant treatment
Preoperative treatment, total
– radiotherapy
– radiochemotherapy
– others
54.2%
32.5%
20%
1.8%
59.5% [4]
5% [4]
54.5% [4]
–
83.7% [3]
55% [3]
28.6% [3]
–
Surgical treatment
Surgical access:
– laparoscopy
Urgent surgeries
Surgery type:
– abdominosacral resection
– Hartmann’s procedure
– anterior resection
– local excision
Protective stoma 
8.6%
4%
20.2%
11.8%
54.2%
1.1%
22.8% ^
–
–
20.4% [4]
1.4% [4]
71.6% # [4]
1.2% [4]
–
38.1% [3]
2.8% [3]
30.5% [3]
19.2% [5]
45.8% *[3]
–
65.3% & [3]
Early results of surgical treatment
Postoperative complications total:
Anastomosis leak 
Repeated surgery
Mortality (30 days after surgery)
21.1%
6.5% ^
–
1.1%
–
–
–
1.1% [8]
38.7% [3]
10.9% & [3]
16% [3] 
2.1% [3]
# Percentage of surgeries defined as “sphincter-saving surgeries”
* Percentage of surgeries defined as “surgeries with primary anastomosis”
^ Percentage with reference to surgeries defined as “anterior resection”
& Percentage with reference to surgeries defined as “surgeries with primary anastomosis” 
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which in the Belgian study is significantly lower than in 
PSSO_01 and DSCA. PROCARE shows a high percentage of 
sphincter-saving surgeries: 71.6%. If resections with primary 
anastomosis (anterior resection) are defined by this term, the 
corresponding data from the DSCA and PSSO_01 projects 
are respectively: 45.8% vs 54.2% The only explanation for 
these differences seems to be the selection of centers and 
the incompleteness of the Belgian register [4]. 
Also noteworthy is the high percentage of protective 
stomata selected in the DSCA material: 65.3%. As early as at 
an early stage of this audit, a clear increase in the proportion 
of protective stomata identified compared to previous data 
collected during the TME trial (1996–1999) was observed: 
70% vs 57% (p < 0.001). However, this fact did not have an 
impact on the reduction of the percentage of anastomosis 
leaks: 11.4% vs 12.1%; p = 0.640 [7]. Observations made then 
by Dutch authors were the basis for designing and defining 
the main objectives of the PSSO_01 study. 
Early results of surgical treatment
The total percentage of complications at the level of 
21% clearly differs from that observed in the Dutch report 
(38.7%). However, the advantage of the PSSO_01 project is 
the prospective registration of the category of complica-
tions according to the Clavien-Dindo classification (Table 
III). Belgian authors reported the percentage of severe com-
plications separately for sphincter-saving surgery and after 
abdominosacral resection: 7.8% vs 5.4% respectively. The 
total postoperative mortality rate was 1.1% [8]. Assuming 
that we consider as serious complications those that fall 
under category III and IV, and the death is classified as ca-
tegory V, the relevant percentages recorded in the PSSO_01 
project are equal: anterior resection — 7.5%; abdominosa-
cral resection — 6.7%; total postoperative mortality rate 
— 1.1%. As we can see, these values are almost identical to 
those reported in the PROCARE study. Interesting insights 
also apply to registered cases of anastomosis leaks. In the 
PSSO_01 project, the total leakage rate after anterior resec-
tion is 6.5%. The DSCA register gives a value of 11%, but it 
should be remembered that it concerns anastomoses after 
rectal cancer resection located up to 12 cm from the anal 
verge. Analyzing a subgroup of patients from the PSSO_01 
study in which the anastomosis was performed up to 10 cm 
from the anal verge, i.e. comparable to DSCA material, the 
percentage of symptomatic leaks is 8%. The higher leakage 
rate recorded in the Dutch report is probably due to the fact 
that the audit covered almost 100% of the centers. 
Final remark
The PSSO initiative through the PSSO_01 project enables 
the presentation of early results of surgical treatment of rectal 
cancer in Poland from a broader perspective than before. 
The results of the analysis of the collected research material 
within the PSSO_01 project so far seem to indicate that it is 
comparable to the material used to create reports presented 
by Dutch and Belgian researchers. This may indicate that it 
will be representative for the entire Polish population. Altho-
ugh the PSSO_01 project does not allow for drawing wider 
conclusions concerning the compliance with the standards 
of qualification for neoadjuvant treatment, the important 
information is that more than half of rectal cancer patients 
receive preoperative treatment, and the percentage of seve-
re postoperative complications does not exceed 70%. This 
value is similar to that given in reports from other European 
countries. Observations relating to the methods of surgical 
treatment that emerge from comparative analysis allow us 
to illustrate the difference in the percentage of laparoscopic 
surgeries performed in Poland in comparison with other 
European countries. At the same time it should be noted 
that the percentages of particular surgery types do not differ 
significantly from those reported in the DSCA. Comparison 
with the PROCARE study reveals significant difficulties in the 
interpretation of results, mainly due to significant differences 
in the reported percentage of Hartmann’s procedures. Early 
surgical treatment results recorded in PSSO_01 are similar to 
those presented in the PROCARE and DSCA studies. 
The functionality of the PSSO application used to collect 
clinical data on surgical treatment of rectal cancer allows for 
its development and creation of further research projects 
focusing on the treatment of patients with this cancer. An 
example can be the PSSO_02 test module added to the 
application and launched in July 2018. The application can 
therefore be regarded as the basic platform for data collec-
tion with the possibility of attaching modules related to a 
specific research project (PSSO_01, PSSO_02). The PSSO_01 
Research Coordination Committee and the Board of the 
Polish Society of Surgical Oncology invite other centers 
that would be interested in participating in current research 
projects, as well as to design new research that would be in 
line with the issues related to the treatment of rectal cancer. 
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